Professor Steven Heys

Professor Steven Heys The University of Aberdeen School of Medicine & Dentistry Professor Steven Heys Chair in Applied Medicine work +44 (0)1224 437968 work +44 (0)1224 552105 pref Polwarth Building Foresterhill Aberdeen AB25 2ZD

Chair in Applied Medicine

BMedBiol,MBChB,MD,PhD,FRCS(Eng),FRCS(Ed),FRCS(Glas),FHEA

Professor Steven Heys

Personal Details

Telephone: +44 (0)1224 437968
+44 (0)1224 552105
Email: s.d.heys@abdn.ac.uk
Address: Polwarth Building
Foresterhill
Aberdeen
AB25 2ZD
hCard

Jump to:

Institute of Medical Sciences

http://www.abdn.ac.uk/ims

Division of Applied Medicine

http://www.abdn.ac.uk/medicine-dentistry/applied-medicine/

School of Medicine and Dentistry

http://www.abdn.ac.uk/medicine-dentistry/


^ top

Biography

Professor Steven D Heys is Head of the Division of Applied Medicine and Co-Director of the Institute of Medical Sciences and an honorary consultant surgeon in the University of Aberdeen and NHS Grampian (special interest in the treatment of breast cancer). He graduated in 1981 and obtained an MD and PhD at the Rowett Research Institute, investigating aspects of nutrition and metabolism, particularly focussing on malignant disease.


^ top

Research Interests

His own interests include the role of nutrition in carcinogenesis, and mechanisms of chemotherapy resistance in breast cancer and delivery of healthcare to patients with malignant disease. This has resulted in the publications of more than 200 peer-reviewed original articles and review papers in these areas. Current research programmes include collaborations both nationally and internationally.


^ top

Current Research

Current research programmes include collaborations both nationally and internationally in these areas.


^ top

Research Grants

Grant funding has been recieved from a variety of sources including CRUK, Breast Cancer Campaign, Chief Scientist's Office, Prostate Cancer Campaign, HTA Programme, European Union, and a variety of industrial and pharmaceutical collaborations. He has a particular interest in helping local fundraising for research and public engagement about research in cancer and nutrition.


^ top

Teaching Responsibilities

He is currently course director of the new Physician Assistant training programme. Previously and for the last 15 years he had led on assessment and then the delivery of undergraduate medical education for a part of the medical curriculum. He is an external examiner at universities in the UK and for the last 12 years he has been  a member and team leader for GMC teams involved in the Quality Assurance of both undergraduate and postgraduate medical training.


^ top

External Responsibilities

External responsibilities have been with the GMC, Breast Cancer Campaign Scientific Advisory Board, Research Allocation Committee of the Royal College of Surgeons of Edinburgh. He has provided specialist advice to UICC, is a referee for national and international journals and grant-awarding charities and is sub-editor of the World Journal of Surgical Oncology.


^ top

Admin Responsibilities

Head, Division of Applied Medicine

Co-Director, Institute of Medical Sciences

University Court member (Senate Assessor)

Operating Board Member, University of Aberdeen


^ top

Publications

Contributions to Journals

Articles

  • Collie-Duguid, ESR., Sweeney, K., Stewart, KN., Miller, ID., Smyth, E. & Heys, SD. (2012). 'SerpinB3, a new prognostic tool in breast cancer patients treated with neoadjuvant chemotherapy'. Breast Cancer Research and Treatment, vol 132, no. 3, pp. 807-818.
    [Online] DOI: 10.1007/s10549-011-1625-9
  • McLay, JS., Stewart, D., George, J., Rore, C. & Heys, SD. (2012). 'Complementary and alternative medicines use by Scottish women with breast cancer: What, why and the potential for drug interactions?'. European Journal of Clinical Pharmacology, vol 68, no. 5, pp. 811-819.
    [Online] DOI: 10.1007/s00228-011-1181-6
  • Heys, SD., Stewart, KN., McKenzie, E., Miller, ID., Wong, SYC., Sellar, G. & Rees, AJ. (2012). 'Characterisation of tumour infiltrating macrophages; impact on response and survival in patients receiving primary chemotherapy for breast cancer'. Breast Cancer Research and Treatment, vol 135, no. 2, pp. 539-548.
    [Online] DOI: 10.1007/s10549-012-2190-6
  • Bruce, J., Thornton, AJ., Scott, NW., Marfizo, S., Powell, R., Johnston, M., Wells, M., Heys, SD. & Thompson, AM. (2012). 'Chronic preoperative pain and psychological robustness predict acute postoperative pain outcomes after surgery for breast cancer'. British Journal of Cancer, vol 107, no. 6, pp. 937-946.
    [Online] DOI: 10.1038/bjc.2012.341
  • Song, H-J, Sneddon, AA., Heys, SD. & Wahle, KWJ. (2012). 'Regulation of fatty acid synthase (FAS) and apoptosis in estrogen-receptor positive and negative breast cancer cells by conjugated linoleic acids'. Prostaglandins, Leukotrienes and Essential Fatty Acids, vol 87, no. 6, pp. 197-203.
    [Online] DOI: 10.1016/j.plefa.2012.09.002
  • Swinton, J., Bain, V., Ingram, S. & Heys, SD. (2011). 'Moving inwards, moving outwards, moving upwards: the role of spirituality during the early stages of breast cancer'. European Journal of Cancer Care, vol 20, no. 5, pp. 640-652.
    [Online] DOI: 10.1111/j.1365-2354.2011.01260.x
  • Wahle, KWJ., Brown, I., Rotondo, D. & Heys, SD. (2011). 'Plant phenolics in the prevention and treatment of cancer'. Advances in Experimental Medicine and Biology, vol 698, pp. 36-51.
    [Online] DOI: 10.1007/978-1-4419-7347-4_4
  • Robertson, C., Ragupathy, SKA., Boachie, C., Fraser, C., Heys, SD., Maclennan, G., Mowatt, G., Thomas, RE., Gilbert, FJ. & and the Mammographic Surveillance Health Technology Assessment Group (2011). 'Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review'. European Radiology, vol 21, no. 12, pp. 2484-2491.
    [Online] DOI: 10.1007/s00330-011-2226-z
    [Online] AURA: Robertson_2011.pdf
  • Brown, I., Wahle, KWJ., Cascio, MG., Smoum, R., Mechoulam, R., Pertwee, RG. & Heys, SD. (2011). 'Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines'. Prostaglandins, Leukotrienes and Essential Fatty Acids, vol 85, no. 6, pp. 305-310.
    [Online] DOI: 10.1016/j.plefa.2011.09.007
  • Robertson, C., Arcot Ragupathy, SK., Boachie, C., Dixon, JM., Fraser, CM., Hernández, R., Heys, S., Jack, W., Kerr, GR., Lawrence, G., MacLennan, G., Maxwell, A., McGregor, J., Mowatt, G., Pinder, S., Ternent, L., Thomas, RE., Vale, L., Wilson, R., Zhu, S. & Gilbert, FJ. (2011). 'The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation'. Health Technology Assessment, vol 15, no. 34, pp. v-vi, 1-322.
    [Online] DOI: 10.3310/hta15340
    [Online] AURA: Robertson_2011.pdf
  • Shaikh, IAA., Brown, I., Wahle, KJ. & Heys, SD. (2010). 'Enhancing Cytotoxic Therapies for Breast and Prostate Cancers with Polyunsaturated Fatty Acids'. Nutrition and Cancer, vol 62, no. 3, pp. 284-296.
    [Online] DOI: 10.1080/01635580903407189
  • Peare, R., Staff, RT. & Heys, SD. (2010). 'The use of FDG_PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature'. Breast Cancer Research and Treatment, vol 123, no. 1, pp. 281-290.
    [Online] DOI: 10.1007/s10549-010-0771-9
  • Heys, S., Galley, H. & Ross, S. (2010). 'Using live theatre in teaching about domestic abuse'. Medical Education, vol 44, no. 5, pp. 503-504.
    [Online] DOI: 10.1111/j.1365-2923.2010.03646.x
  • Murray, G., Patimalla, S., Stewart, KN., Miller, ID. & Heys, SD. (2010). 'Profiling the expression of cytochrome P450 in breast cancer'. Histopathology, vol 57, no. 2, pp. 202-211.
    [Online] DOI: 10.1111/j.1365-2559.2010.03606.x
  • Brown, I., Cascio, MG., Wahle, KWJ., Smoum, R., Mechoulam, R., Ross, RA., Pertwee, RG. & Heys, SD. (2010). 'Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines'. Carcinogenesis, vol 31, no. 9, pp. 1584-1591.
    [Online] DOI: 10.1093/carcin/bgq151
  • Ternent, L., MacLennan, G., Heys, SD., Gilbert, F., Vale, L. & Mammographic Surveillance HTA Grp (2010). 'Surveillance following breast cancer: is it cost-effective?'. Breast Cancer Research, vol 12, no. 3, pp. 5-6.
    [Online] DOI: 10.1186/bcr2658
  • Nanthakumaran, S., Brown, I., Heys, SD. & Schofield, AC. (2009). 'Inhibition of gastric cancer cell growth by arginine: Molecular mechanisms of action'. Clinical Nutrition, vol 28, no. 1, pp. 65-70.
    [Online] DOI: doi:10.1016/j.clnu.2008.10.007
  • Brown, I., Halliday, S., Greig, H., Heys, SD., Wallace, HM. & Schofield, AC. (2009). 'Genetic polymorphism in ornithine decarboxylase and risk of breast cancer'. Familial Cancer, vol 8, no. 4, pp. 307-311.
    [Online] DOI: 10.1007/s10689-009-9237-9
  • Eremin, O., Walker, M., Simpson, E., Heys, SD., Ah-See, A., Hutcheon, A., Ogston, KN., Sarkar, TK., Segar, A. & Walker, LG. (2009). 'Immunomodulatory effects of relaxation training and guided imagery in women with locally advanced breast cancer undergoing multimodality therapy'. Breast, vol 18, no. 1, pp. 17-25.
    [Online] DOI: 10.1016/j.breast.2008.09.002
  • Dawson, A., Bruce, S., Heys, SD. & Stewart, I. (2009). 'Student views on the introduction of anatomy teaching packages into clinical attachments'. Clinical Anatomy, vol 22, no. 2, pp. 267-272.
    [Online] DOI: 10.1002/ca.20732
  • Dawson, A., Bruce, S., Heys, SD. & Stewart, IJ. (2009). 'Student views on the introduction of anatomy learning packages into clinical attachments'. Clinical Anatomy, vol 22, no. 2, pp. 267-272.
    [Online] DOI: 10.1002/ca.20732
  • Robertson, C., Thomas, RE., Heys, SD., Maxwell, A., Gilbert, FJ. & Mammographic Surveillance Hlth (2009). 'A survey of UK breast surgeons and radiologists to determine current and aspired mammography surveillance practice after treatment for primary breast cancer'. Breast Cancer Research, vol 11, no. Suppl. 2, pp. 14.
    [Online] DOI: 10.1186/bcr2384
  • Dawson, A., Bruce, S., Heys, SD. & Stewart, IJ. (2009). 'Introducing anatomy learning packages into clinical attachments'. Journal of Anatomy, vol 214, no. 5, pp. 778-802.
    [Online] DOI: 10.1111/j.1469-7580.2009.01069.x
  • Shaikh, IAA., Brown, I., Schofield, AC., Wahle, KJ. & Heys, SD. (2008). 'Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: The role of genes associated with the NF-kappaB pathway'. The Prostate, vol 68, no. 15, pp. 1635-1646.
    [Online] DOI: 10.1002/pros.20830
  • Reid, DM., Doughty, J., Eastell, R., Heys, SD., Howell, A., McCloskey, EV., Powles, T., Selby, P. & Coleman, RE. (2008). 'Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group'. Cancer Treatment Reviews, vol 34, no. Suppl. 1, pp. S3-S18.
    [Online] DOI: 10.1016/j.ctrv.2008.03.007
  • Wahle, KWJ. & Heys, SD. (2008). 'Atherosclerosis: cell biology and lipoproteins'. Current Opinion in Lipidology, vol 19, no. 4, pp. 435-437.
    [Online] DOI: 10.1097/MOL.0b013e328306f0cc
  • Sangrithi-Wallace, J., McDonald, SL., Brown, I., Heys, SD. & Schofield, AC. (2008). 'Identifying candidate genes on chromosome 12p in docetaxel-resistant breast cancer cells'. Scottish Medical Journal, vol 53, no. 1, pp. 51-51.
  • McDermott, GM., Welch, A., Staff, RT., Gilbert, FJ., Schweiger, LF., Semple, SIK., Smith, TAD., Hutcheon, AW., Miller, ID., Smith, IC. & Heys, SD. (2007). 'Monitoring primary breast cancer throughout chemotherapy using FDG-PET'. Breast Cancer Research and Treatment, vol 102, no. 1, pp. 75-84.
    [Online] DOI: 10.1007/S10549-006-9316-7
  • Sangrithi-Wallace, JN., Brown, I., Heys, SD. & Schofield, AC. (2007). 'Role of Caveolin-1 expression in docetaxel resistance in breast cancer cells'. European Journal of Cancer. Supplement, vol 5, no. 3, O-50, pp. 16-16.
    [Online] DOI: 10.1016/S1359-6349(07)71740-8
  • Heys, SD., Smith, IC., Ross, JAS., Gilbert, FJ., Brooks, J., Semple, S., Miller, ID., Hutcheon, A., Sarkar, T. & Eremin, O. (2006). 'A pilot study with long term follow up of hyperbaric oxygen pretreatment in patients with locally advanced breast cancer undergoing neo-adjuvant chemotherapy'. Undersea & Hyperbaric Medicine, vol 33, no. 1, pp. 33-43.
  • Semple, SIK., Staff, RT., Heys, SD., Redpath, TW., Welch, A., Ahearn, TS., Hutcheon, AW. & Gilbert, FJ. (2006). 'Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration'. Annals of Oncology, vol 17, pp. 1393-1398.
    [Online] DOI: 10.1093/annonc/mdl136
  • Denison, AR., Currie, AE., Laing, MR. & Heys, SD. (2006). 'Good for them or good for us? The role of academic guidance interviews'. Medical Education, vol 40, no. 12, pp. 1188-1191.
    [Online] DOI: 10.1111/j.1365-2929.2006.02629.x
  • Rotariu, O., Udrea, LE., Strachan, NJC., Heys, SD., Schofield, AC., Gilbert, FJ. & Badescu, V. (2006). 'Studies of magnetic carrier particles capture for blood vessel embolization'. Journal of Optoelectronics and Advanced Materials, vol 8, no. 5, pp. 1758-1760.
  • Song, HJ., Sneddon, AA., Heys, SD. & Wahle, KWJ. (2006). 'Induction of apoptosis and inhibition of NF-kappa B activation in human prostate cancer cells by the cis-9, trans-11 but not the trans-10, cis-12 isomer of conjugated linoleic acid'. The Prostate, vol 66, no. 8, pp. 839-846.
    [Online] DOI: 10.1002/pros.20351
  • McDonald, S., Chipchase, H., Needham, M., Wallace, J., Stevenson, DAJ., Heys, SD., Brown, I. & Schofield, AC. (2005). 'Identification of minimal regions of genomic alteration associated with docetaxel resistance in breast cancer cells'. European Journal of Surgical Oncology, vol 31, pp. 1059-1059.
  • Brown, I., McDonald, S., Hutcheon, AW., Stevenson, DAJ., Heys, SD. & Schofield, AC. (2005). 'Genetic pathways involved in the evolution of acquired resistance to docetaxel in breast cancer cells'. Proceedings of the American Association for Cancer Research, vol 46, pp. 776-776.
  • Nanthakumaran, S., Brown, I., Heys, SD. & Schofield, AC. (2005). 'Arginine inhibits gastric cancer cell growth but increases invasive potential'. European Journal of Surgical Oncology, vol 31, pp. 1067-1067.
    [Online] DOI: 10.1016/j.ejso.2005.03.013
  • Brown, I., Fragiadaki, M., McDonald, S., Heys, SD. & Schofield, AC. (2005). 'Modulation of p27 expression can alter docetaxel-induced cytotoxicity in breast cancer cells'. European Journal of Surgical Oncology, vol 31, pp. 1073-1073.
  • Shalli, K., Brown, I., Heys, SD. & Schofield, AC. (2005). 'Altered expression of ß-tubuin isotypes in breast cancer cells resistant to docetaxel'. FASEB Journal, vol 19, pp. 1299-1301.
    [Online] DOI: 10.1096/FJ.04-3178FJE
  • Debnath, D., Brown, I., Heys, SD., Thies, F. & Schofield, AC. (2005). 'Cyclin D1 and p27 (Kip1) dependent G1 cell cycle arrest but no significant apoptosis are associated with lycopene inducced inhibition of growth of WiDR human colon cancer cells'. Diseases of the Colon & Rectum, vol 48, pp. 604-604.
  • Chaturvedi, S., McLaren, C., Schofield, AC., Ogston, KN., Sarkar, TK., Hutcheon, AW., Miller, ID. & Heys, SD. (2005). 'Patterns of local and distant disease relapse in patients with breast cancer treated with primary chemotherapy: do patients with a complete pathological response differ from those with residual tumour in the breast?'. Breast Cancer Research and Treatment, vol 93, no. 2, pp. 151-158.
    [Online] DOI: 10.1007/S10549-005-4615-Y
  • Brown, I., Fragiadaki, M., Heys, SD. & Schofield, AC. (2005). 'Definition of the evolutionary pathway to acquired docetaxel resistance'. European Journal of Cancer, vol 3, pp. 27-27.
  • Heys, SD., Schofield, AC., Wahle, KWJ. & Caballero, MG. (2005). 'Nutrition and the surgical patient: Triumphs and challenges'. The Surgeon, vol 3, no. 3, pp. 139-144.
    [Online] DOI: 10.1016/S1479-666X(05)80033-2
  • McDonald, S., Stevenson, DAJ., Moir, S., Hutcheon, AW., Haites, NE., Heys, SD. & Schofield, AC. (2005). 'Genomic changes identified by comparative genomic hybridisation in docetaxel-resistant breast cancer cell lines'. European Journal of Cancer, vol 41, no. 7, pp. 1086-94.
    [Online] DOI: 10.1016/j.ejca.2005.01.018
  • Brown, I., McDonald, SL., Gadd, TJ., Miliara, S., Needham, MM., Stevenson, DAJ., Heys, SD. & Schofield, AC. (2005). 'Identifying genetic pathways during the evolution of docetaxel resistance in breast cancer cells'. British Journal of Surgery, vol 92, no. 10, pp. 1308.
  • Shalli, K., Brown, I., Cash, P., Stewart, E., Heys, SD. & Schofield, AC. (2005). 'A proteomic approach to docetaxel resistance in breast cancer cells'. British Journal of Surgery, vol 92, no. 10, pp. 1313-1313.
  • Ogston, KN., Miller, ID., Schofield, AC., Spyrantis, A., Pavlidou, E., Sarkar, TK., Hutcheon, AW., Payne, S. & Heys, SD. (2004). 'Can patients' likelihood of benefiting from primary chemotherapy for breast cancer be predicted before commencement of treatment?'. Breast Cancer Research and Treatment, vol 86, no. 2, pp. 181-189.
    [Online] DOI: 10.1023/B:BREA.0000032986.00879.d7
  • Brown, I., Halliday, S., Greig, H., Haites, NE., Wallace, HM., Heys, SD. & Schofield, AC. (2004). 'Genetic polymorphism in ornithine decarboxylase and risk of breast cancer'. European Journal of Surgical Oncology, vol 30, pp. 1028-1028.
  • Ochoa, JJ., Farquharson, AJ., Grant, I., Moffat, LE., Heys, SD. & Wahle, KW. (2004). 'Conjugated linoleic acids (CLA's) decrease prostate cancer cell proliferation: different molecular mechanisms for cis-9, trans-11 and trans-10, cis-12 isomers'. Carcinogenesis.
    [Online] DOI: 10.1093/CARCIN/BGH116
  • Shalli, K., Cash, P., Brown, I., Heys, SD. & Schofield, AC. (2004). 'Proteomic analysis of human breast cancer cells with acquired resistance to docetaxel'. European Journal of Surgical Oncology, vol 30, pp. 1005-1006.
    [Online] DOI: 10.1016/j.ejso.2004.09.008
  • Yong, SM., Stewart, KN., Pollock, AM., Babalghith, AO., Pavlidou, E., Alhasso, A., Heys, SD., Brown, PAJ., Schofield, AC. & N'Dow, JMO. (2004). 'Membrane bound mucins MUC1, MUC4 and MUC16/CA125 are preferentially expressed in muscle invasive bladder cancer'. Journal of Urology, vol 171, pp. 259-259.
  • McDonald, S., Stevenson, DAJ., Brown, I., Hutcheon, AW., Heys, SD. & Schofield, AC. (2004). 'Genetic pathways in "early" and "late" acquired resistance to docetaxel in breast cancer cells'. European Journal of Surgical Oncology, vol 30, pp. 1010-1010.
  • Debnath, D., Brown, I., Thies, F., Heys, SD. & Schofield, AC. (2004). 'In vitro inhibition of colon cancer cell WiDR is not mediated through p53 and bcl2'. European Journal of Surgical Oncology, vol 30, pp. 1028-1028.
  • Shalli, K., Brown, I., Heys, SD. & Schofield, AC. (2004). 'Altered expression of beta-tubulin isotypes in breast cancer cells: a mechanism of docetaxel resistance'. British Journal of Surgery, vol 91, pp. 38-38.
    [Online] DOI: 10.1002/bjs.4372
  • Semple, SIK., Gilbert, FJ., Redpath, TW., Staff, RT., Ahearn, TS., Welch, A., Heys, SD., Hutcheon, AW., Smyth, EH. & Chaturvedi, S. (2004). 'The relationship between vascular and metabolic characteristics of primary breast tumours'. European Radiology, vol 14, no. 11, pp. 2038-2045.
    [Online] DOI: 10.1007/s00330-004-2454-6
  • Yong, SM., Stewart, KN., Babalghith, AO., Grigor, KN., Pavlidou, E., Heys, SD., N'Dow, JMO. & Schofield, AC. (2004). 'Membrane-bound mucin expression in bladder cancer'. European Journal of Surgical Oncology, vol 30, pp. 1027-1028.
  • Lim, KP., McClinton, S., Heys, SD., Wahle, KW. & Schofield, AC. (2004). 'Downregulation of Bcl-2 and Bax proteins in LNCaP cells treated with fatty acid and docetaxel'. British Journal of Surgery, vol 91, pp. 1230-1230.
  • Brown, I., Shalli, K., McDonald, S., Moir, SE., Hutcheon, AW., Heys, SD. & Schofield, AC. (2004). 'Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells'. Breast Cancer Research, vol 6, no. 5, pp. R601-R607.
    [Online] DOI: 10.1186/bcr918
  • Heys, SD., Sarkar, TK. & Hutcheon, AW. (2004). 'Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer'. Expert Opinion on Pharmacotherapy, vol 5, no. 10, pp. 2147-2157.
    [Online] DOI: 10.1517/14656566.5.10.2147
  • Chesser, AMS., Laing, M., Miedzybrodzka, ZH., Brittenden, J. & Heys, SD. (2004). 'Factor analysis can be a useful standard setting tool in a high stakes OSCE assessment'. Medical Education, vol 38, pp. 825-831.
    [Online] DOI: 10.1111/j.1365-2929.2004.01821.x
  • Shalli, K., Brown, I., Heys, SD. & Schofield, AC. (2004). 'Altered expression of beta-tubulin isotypes associated with docetaxel resistance in breast cancer cells'. European Journal of Surgical Oncology, vol 30, pp. 1018-1018.
  • Halliday, S., Greig, H., Brown, I., Heys, SD., Schofield, AC. & Wallace, HM. (2004). 'Influence of ornithine decarboxylase polymorphism on human breast cancer development'. Toxicology, vol 202, pp. 117-119.
  • Pandey, M., Heys, SD. & Lowenfels, AB. (2004). 'World Journal of Surgical Oncology: One year of Open Access publishing'. World Journal of Surgical Oncology, vol 2, no. 1.
    [Online] DOI: 10.1186/1477-7819-2-14
  • Song, HJ., Sneddon, AA., Barker, PA., Bestwick, C., Choe, SN., McClinton, S., Grant, I., Rotondo, D., Heys, SD. & Wahle, KWJ. (2004). 'Conjugated linoleic acid inhibits proliferation and modulates protein kinase C isoforms in human prostate cancer cells'. Nutrition and Cancer, vol 49, pp. 100-108.
    [Online] DOI: 10.1207/s15327914nc4901_14
  • Heys, SD., Schofield, AC. & Wahle, KWJ. (2004). 'Immunonutrition in clinical practice'. Nutrición Hospitalaria, vol 19, no. 6, pp. 325-332.
  • Semple, SIK., Staff, RT., Gilbert, FJ., Redpath, TW., Ahearn, TS., Welch, A. & Heys, SD. (2004). 'The correlation between FDG PET and the vascular characteristic of breast tumours measured using dynamic contrast enhanced MRI'. European Journal of Nuclear Medicine and Molecular Imaging, vol 31, no. Suppl., pp. S231.
  • Ogston, KN., Miller, ID., Payne, S., Hutcheon, AW., Sarkar, TK., Smith, I., Schofield, AC. & Heys, SD. (2003). 'A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival'. Breast, vol 12, no. 5, pp. 320-327.
    [Online] DOI: 10.1016/S0960-9776(03)00106-1
  • Brown, I., Moir, SE., Heys, SD. & Schofield, AC. (2003). 'Molecular changes associated with docetaxel resistance in breast cancer cells using cDNA microarray analyses'. Scottish Medical Journal, vol 48, pp. 127-127.
  • Debnath, D., Brown, I., Heys, SD., Thies, F. & Schofield, AC. (2003). 'Inhibition of colon cancer cell growth by the antioxidant lycopene'. European Journal of Surgical Oncology, vol 29, pp. 788-788.
    [Online] DOI: 10.1016/j.ejso.2003.08.014
  • McDonald, S., Moir, SE., Stevenson, DAJ., Heys, SD. & Schofield, AC. (2003). 'Amplification of 7q is involved in resistance to docetaxel chemotherapy in breast cancer'. European Journal of Surgical Oncology, vol 29, pp. 786-786.
  • Hutcheon, AW., Heys, SD. & Sarkar, TK. (2003). 'Neoadjuvant docetaxel in locally advanced breast cancer'. Breast Cancer Research and Treatment, pp. S19-24.
    [Online] DOI: 10.1023/A:1024333725148
  • Shalli, K., Brown, I., Moir, SE., Heys, SD. & Schofield, AC. (2003). 'A novel mechanism of docetaxel resistance in breast cancer cells: class III beta-tubulin overexpression'. European Journal of Surgical Oncology, vol 29, pp. 824-824.
  • McIntosh, SA., Ogston, KN., Payne, S., Miller, ID., Sarkar, TK., Hutcheon, AW. & Heys, SD. (2003). 'Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy'. American Journal of Surgery, vol 185, no. 6, pp. 525-531.
    [Online] DOI: 10.1016/S0002-9610(03)00078-3
  • Heys, SD. & Chaturvedi, S. (2003). 'Primary chemotherapy in breast cancer: The beginning of the end or the end of the beginning for the surgical oncologist?'. World Journal of Surgical Oncology, vol 1, no. 1.
    [Online] DOI: 10.1186/1477-7819-1-14
  • Kirk, HJ. & Heys, SD. (2003). 'Immunonutrition'. British Journal of Surgery, vol 90, no. 12, pp. 1459-1460.
    [Online] DOI: 10.1002/bjs.4368
  • Lim, KP., Kirk, H., Wahle, KW., McClinton, S., Heys, SD. & Schofield, AC. (2003). 'Docosahexaenoic acid synergistically enhances the anti-tumour effect of docetaxel in prostate cancer cells'. Scottish Medical Journal, vol 48, pp. 128-129.
  • Lim, KP., McClinton, S., Wahle, KW., Heys, SD. & Schofield, AC. (2003). 'Synergistic effect of fatty acids on docetaxel-induced apoptosis in prostate cancer cells'. European Journal of Surgical Oncology, vol 29, pp. 786-786.
  • McDonald, S., Moir, SE., Stevenson, DAJ., Heys, SD. & Schofield, AC. (2003). 'Detection of a common amplification of 7q in docetaxel resistant breast cancer cell lines by comparative hybridisation'. European Journal of Cancer, vol 1, pp. 16-16.
  • McDonald, S., Moir, SE., Babalghith, AO., Stevenson, DAJ., Heys, SD., Wallace, HM. & Schofield, AC. (2003). 'Characterisation of docetaxel resistant breast cancer cell lines'. British Journal of Cancer, vol 88, pp. S59-S59.
  • Debnath, D., Brown, I., Bilgi, M., Heys, SD., Thies, F. & Schofield, AC. (2003). 'In vitro inhibitory effects of lycopene on human cancer cells is associated with apoptosis'. British Journal of Cancer, vol 88, pp. S26-S26.
  • Brown, I., McDonald, S., Moir, SE., Heys, SD. & Schofield, AC. (2003). 'Bcl-2 overexpression in a docetaxel resistant breast cancer cell line'. British Journal of Cancer, vol 88, no. Sup1.
  • McDonald, S., Stevenson, DAJ., Heys, SD. & Schofield, AC. (2003). 'Amplification of HER2 is not involved in resistance to docetaxel in breast cancer cell lines'. European Journal of Surgical Oncology, vol 29, pp. 820-821.
  • Boddie, DE., Currie, DG., Eremin, O. & Heys, SD. (2003). 'Immune suppression and isolated severe head injury: a significant clinical problem'. British Journal of Neurosurgery, vol 17, no. 5, pp. 405-417.
    [Online] DOI: 10.1080/02688690310001611198
  • Brown, I., Heys, SD. & Schofield, AC. (2003). 'From peas to "chips" - the new millennium of molecular biology: a primer for the surgeon'. World Journal of Surgical Oncology, vol 1, no. 1.
    [Online] DOI: 10.1186/1477-7819-1-21
  • Brown, I., Moir, SE., Hutcheon, AW., Heys, SD. & Schofield, AC. (2003). 'Downregulation of p27 is a common event in resistance to docetaxel'. European Journal of Surgical Oncology, vol 29.
    [Online] DOI: 10.1016/j.ejso.2003.09.009
  • Lim, KP., McClinton, S., Kirk, H., Heys, SD., Wahle, KJ. & Schofield, AC. (2003). 'Fatty acids can enhance the anti-tumour effect of docetaxel in PC3 androgen-insenstitive prostate cance cells'. BJU International, vol 92, pp. 828-829.
  • McDonald, S., Babalghith, AO., Brown, I., Moir, SE., Stevenson, DAJ., Heys, SD. & Schofield, AC. (2003). 'Comparative genomic hybridisation analyses of genetic changes associated with docetaxel resistance in breast cancer cells'. Scottish Medical Journal, vol 48, pp. 130-130.
  • Kirk, H., Brown, I., Heys, SD. & Schofield, AC. (2003). 'Modulation of gastric cancer cell invasion and E-cadherin gene expression by L-arginine'. European Journal of Surgical Oncology, vol 29, pp. 795-795.
    [Online] DOI: 10.1016/j.ejso.2003.08.017
  • Semple, SIK., Gilbert, FJ., Redpath, TW., Ahearn, TS., Welch, A., Hutcheon, AW., Heys, SD., Smyth, EH., Miller, ID. & Smith, IC. (2003). 'Correlation of MRI/PET rim enhancement in breast cancer: a delivery related phenomenon with therapy implications?'. The Lancet Oncology, vol 4, no. 12, pp. 759-759.
    [Online] DOI: 10.1016/S1470-2045(03)01281-6
  • Keith, DJ., Walker, MB., Walker, LG., Heys, SD., Sarkar, TK., Hutcheon, AW. & Eremin, O. (2003). 'Women who wish breast reconstruction: characteristics, fears, and hopes'. Plastic and Reconstructive Surgery, vol 111, no. 3, pp. 1051-1056.
    [Online] DOI: 10.1097/01.PRS.0000046247.56810.40
  • Wahle, KW., Rotondo, D. & Heys, SD. (2003). 'Polyunsaturated fatty acids and gene expression in mammalian systems'. Proceedings of the Nutrition Society, vol 62, no. 2, pp. 349-360.
    [Online] DOI: 10.1079/PNS2003249
  • Brown, I., Moir, SE., Heys, SD. & Schofield, AC. (2003). 'Molecular changes involved in docetaxel resistance in breast cancer cells'. European Journal of Cancer, vol 1, pp. 16-17.
  • Schofield, AC., Pavlidou, E., Miller, ID., Spyrantis, A., Hutcheon, AW. & Heys, SD. (2003). 'Predicting response to primary chemotherapy in breast cancer'. British Journal of Surgery, vol 90, pp. 626-627.
  • Gardiner, E., Ogston, KN., Smith, IC., Welch, A., Sharp, PF., Hutcheon, AW., Ah-See, AK., Eremin, O. & Heys, SD. (2002). '[F-18]fluorodeoxy-D-glucose positron emission tomography may predict the pathological response of breast cancer to primary chemotherapy'. British Journal of Surgery, vol 88, pp. 761-767.
  • Schofield, AC., Pavlidou, E., Spyrantis, A., Miller, ID., Ogston, KN., Sarkar, TK., Chaturvedi, S., Hutcheon, AW. & Heys, SD. (2002). 'Biological markers predict response to chemotherapy in breast tumours'. European Journal of Surgical Oncology, vol 28, pp. 794-794.
  • Heys, SD., Hutcheon, AW., Sarkar, TK., Ogston, KN., Miller, ID., Payne, S., Smith, I., Walker, LG. & Eremin, O. (2002). 'Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial'. Clinical Breast Cancer, vol 3, no. Suppl 2, pp. S69-74.
  • Majumder, B., Wahle, KW., Moir, SE., Schofield, AC., Choe, SN., Farquharson, AJ., Grant, I. & Heys, SD. (2002). 'Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells'. FASEB Journal, vol 16, no. 11, pp. 1447-1449.
    [Online] DOI: 10.1096/FJ.01-0720FJE
  • McIntosh, SA., Panchalingam, L., Payne, S., Miller, ID., Sarkar, TK., Hutcheon, AW. & Heys, SD. (2002). 'Freehand core biopsy in breast cancer: an accurate predictor of tumour grade following neoadjuvant chemotherapy?'. Breast, vol 11, no. 6, pp. 496-500.
    [Online] DOI: 10.1054/brst.2002.0466
  • Wahle, KW. & Heys, SD. (2002). 'Cell signal mechanisms, conjugated linoleic acids (CLAs) and anti-tumorigenesis'. Prostaglandins, Leukotrienes and Essential Fatty Acids, vol 67, no. 2-3, pp. 183-186.
    [Online] DOI: 10.1054/plef.2002.0416
  • Kirk, H., Schofield, AC. & Heys, SD. (2002). 'Immunonutrition - the potential for harm?'. European Journal of Surgical Oncology, vol 28, pp. 801-801.
  • Schofield, AC., Fite, A., Wahle, KW. & Heys, SD. (2002). 'Dietary fatty acids modulate the anti-tumour effect of docetaxel chemotherapy in breast cancer cells'. Proceedings of the American Association for Cancer Research, vol 43, pp. 919-919.
  • Sharp, L., Little, J., Schofield, AC., Pavlidou, E., Cotton, SC., Miedzybrodzka, ZH., Baird, J., Haites, NE., Heys, SD. & Grubb, DA. (2002). 'Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR)'. Cancer Letters, vol 181, no. 1, pp. 65-71.
    [Online] DOI: 10.1016/S0304-3835(02)00030-7
  • Barker, PA., Duncan, L., McClinton, S., Wahle, KW., Heys, SD. & Schofield, AC. (2002). 'Conjugated linoleic acid (CLA) inhibits cancer cell growth differentially in androgen-sensitive and androgen-independent human prostate cancer cells'. European Journal of Surgical Oncology, vol 28, pp. 777-777.
  • Smith, IC., Heys, SD., Hutcheon, AW., Miller, ID., Payne, S., Gilbert, FJ., Ah-See, AK., Eremin, O., Walker, LG., Sarkar, TK., Eggleton, SP. & Ogston, KN. (2002). 'Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel'. Journal of Clinical Oncology, vol 20, no. 6, pp. 1456-1466.
    [Online] DOI: 10.1200/JCO.20.6.1456
  • Lim, KP., Wahle, KW., Heys, SD. & Schofield, AC. (2002). 'Modulation of docetaxel-induced cytotoxicity by fatty acids on human prostate cancer cells'. European Journal of Surgical Oncology, vol 28, pp. 805-805.
  • McLaren, C., Carden, C., Chaturvedi, S., Dewar, J., Schofield, AC., Ogston, KN. & Heys, SD. (2002). 'Patterns of distant metastases in patients with breast cancer treated with primary chemotherapy'. European Journal of Surgical Oncology, vol 28, pp. 764-765.
  • Jmor, S., Al-Sayer, H., Heys, SD., Payne, S., Miller, ID., Ah-See, AK., Hutcheon, AW., Eremin, O. & Jimor, S. (2002). 'Breast cancer in women aged 35 and under: prognosis and survival'. Journal of the Royal College of Surgeons of Edinburgh, vol 47, no. 5, pp. 693-699.
  • Miedzybrodzka, ZH., Sharp, L., Richardson, J., Schofield, AC., McGuigan, FEA., Heys, SD., Little, J. & Haites, NE. (2001). 'Vitamin D and breast cancer: interaction between dietary vitamin D and genetic variation in the vitamin D receptor may be implicated in the aetiology of breast cancer'. EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics., vol 9, no. Supplement 1, pp. 1411.
  • Heys, SD. & Wahle, KW. (2001). 'Targeted nutrition in the critically ill: a therapeutic modality for the new millennium?'. Nutrition, vol 17, no. 1, pp. 57-58.
    [Online] DOI: 10.1016/S0899-9007(00)00484-6
  • Fite, A., Schofield, AC., Wahle, KW. & Heys, SD. (2001). 'Potentiation of anti-tumour effect of docetaxel by conjugated linoleic acid in breast cancer'. European Journal of Surgical Oncology, vol 27, pp. 798-798.
  • Schofield, AC., Payne, SN., Langlois, NEI. & Heys, SD. (2001). 'Expression of BRCA1 does not predict survival in patients with colorectal cancer'. European Journal of Surgical Oncology, vol 27, pp. 795-796.
  • Majumder, B., Moir, SE., Schofield, AC., Wahle, KW. & Heys, SD. (2001). 'The anti-tumour effects of conjugated linoleic acid in breast cancer are mediated both by p53 dependent and independent pathways'. European Journal of Cancer, vol 37, pp. 28-29.
    [Online] DOI: 10.1016/S0959-8049(01)80115-5
  • Majumder, B., Schofield, AC., Moir, SE., Wahle, KW. & Heys, SD. (2001). 'Conjugated linoleic acid restores growth suppression function in mutant p53-expressing breast cancer cells'. European Journal of Surgical Oncology, vol 27, pp. 792-792.
  • Barker, PA., Schofield, AC., Moir, SE., Song, V., McClinton, S., Wahle, KW. & Heys, SD. (2001). 'Inhibition of prostate cancer by conjugated linoleic acid'. European Journal of Surgical Oncology, vol 27, pp. 785-785.
  • Schofield, AC., sharp, L., Pavlidou, E., Miedzybrodzka, ZH., Heys, SD., little, J. & Haites, NE. (2001). 'Folate and breast cancer: the role of polymorphsisms in methylenetetrahydrofolate reductase (MTHFR)'. EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics., vol 9, pp. 275-275.
  • Ashkanani, F., Sarkar, TK., Needham, G., Coldwells, A., Ah-See, AK., Gilbert, FJ., Hutcheon, AW., Eremin, O. & Heys, SD. (2001). 'What is achieved by mammographic surveillance after breast conservation treatment for breast cancer?'. American Journal of Surgery, vol 182, no. 3, pp. 207-210.
    [Online] DOI: 10.1016/S0002-9610(01)00704-8
  • Heys, SD. (2001). 'Evolution of breast cancer management: focus on neoadjuvant chemotherapy'. Breast Cancer, vol 8, no. 4, pp. 339-350.
    [Online] DOI: 10.1007/BF02967535
  • Walker, LG., Heys, SD., Walker, MB., Ogston, K., Miller, ID., Hutcheon, AW., Sarkar, TK., Ah-See, AK. & Eremin, O. (1999). 'Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer'. European Journal of Cancer, vol 35, no. 13, pp. 1783-1788.
    [Online] DOI: 10.1016/S0959-8049(99)00169-0
  • ElTahir, A., Jibril, JA., Squair, J., Heys, SD., Ah-See, AK., Needham, G., Deans, H., Gilbert, FJ., McKean, M., Smart, L. & Eremin, O. (1998). 'Accuracy of one-stop diagnosis for 1110 patients presenting to a symptomatic breast clinic'. British Journal of Surgery, vol 85, no. 5, pp. 688-688.
  • Purasiri, P., Abdalla, M., Heys, SD., AhSee, AK., McKean, ME., Gilbert, FJ., Needham, G., Deans, H. & Eremin, O. (1996). 'A novel diagnostic index for use in the breast clinic'. Journal of the Royal College of Physicians of Edinburgh, vol 41, no. 1, pp. 30-34.
  • Brittenden, J., Heys, SD., Miller, I., Sarkar, TK., Hutcheon, AW., Needham, G., Gilbert, FJ., McKean, M., Ahsee, AK. & Eremin, O. (1994). 'Dietary Supplementation with L-Arginine in Patients with Breast-Cancer (greater-than-4 cm) Receiving Multimodality Treatment: report of a feasability study'. British Journal of Cancer, vol 69, no. 5, pp. 918-921.
  • MCNURLAN, MA., Heys, SD., PARK., KGM., Broom, J., Brown, DS., EREMIN., O. & GARLICK, PJ. (1994). 'Tumor and Host Tissue Responses to Branched-Chain Amino-Acid Supplementation of Patients with Cancer'. Clinical Science, vol 86, no. 3, pp. 339-345.
  • Maltin, CA., Delday, MI., Watson, JS., Heys, SD., Nevison, IM., Ritchie, IK. & Gibson, PH. (1993). 'Clenbuterol, A BETA-Adrenoceptor Agonist, Increases Relative Muscle Strength in Orthopedic Patients'. Clinical Science, vol 84, no. 6, pp. 651-654.
  • Heys, SD., Park, KG., McNurlan, MA., Calder, AG., Buchan, V., Blessing, K., Eremin, O. & Garlick, PJ. (1991). 'Measurement of tumour protein synthesis in vivo in human colorectal and breast cancer and its variability in separate biopsies from the same tumour'. Clinical Science, vol 80, no. 6, pp. 587-593.
  • Heys, SD., PARK., KGM., MCNURLAN., MA., Milne, E., EREMIN., O., WERNERMAN, J., KEENAN, RA. & GARLICK, PJ. (1991). 'Stimulation of Protein-Synthesis of Protein in Human Tumors by Parenteral-Nutrition EVIDENCE FOR MODULATION OF TUMOR-GROWTH: Evidence for Modulation of Tumor-Growth'. British Journal of Surgery, vol 78, no. 4, pp. 483-487.
  • MCNURLAN, MA., ESSEN., P., Heys, SD., Buchan, V., GARLICK., PJ. & WERNERMAN, J. (1991). 'Measurement of Protein-Synthesis in Human Skeletal-Muscle: Further Investigation of the Flooding Technique'. Clinical Science, vol 81, no. 4, pp. 557-564.
  • BALLMER, PE., MCNURLAN., MA., Milne, E., Heys, SD., Buchan, V., Calder, AG. & GARLICK, PJ. (1990). 'Measurement of Albumin Synthesis in Humans: A new approach employing stable isotopes'. AMERICAN JOURNAL OF PHYSIOLOGY, vol 259, no. 6, pp. E797-E803.
  • Heys, SD., MCNURLAN., MA., PARK., KGM., Milne, E. & GARLICK, PJ. (1990). 'Base-Line Measurements for Stable Isotope Studies: An alternative to biopsy'. Biomedical & Environmental Mass Spectrometry, vol 19, no. 3, pp. 176-178.

Scientific Reviews

  • Fite, A., Goua, M., Wahle, KWJ., Schofield, AC., Hutcheon, AW. & Heys, SD. (2007). 'Potentiation of the anti-tumour effect of docetaxel by conjugated linoleic acids (CLAs) in breast cancer cells in vitro'. Prostaglandins, Leukotrienes and Essential Fatty Acids, vol 77, no. 2, pp. 87-96.
    [Online] DOI: 10.1016/j.plefa.2007.08.004

Abstracts

  • Haggarty, P., Hoad, G., Scott, P., Simpson, L., Samad, A., Smyth, E., Heys, SD. & Haggarty, P. (2010). 'Imprinted gene methylation in blood and risk of breast cancer'. European Journal of Cancer. Supplement, vol 8, no. 6, pp. 9.
    [Online] DOI: 10.1016/j.ejcsup.2010.06.024
  • Collie-Duguid, ESR., Sweeney, K., Stewart, KN., Miller, ID. & Heys, SD. (2010). 'SerpinB3, a biomarker of taxane benefit in breast cancer'. European Journal of Cancer. Supplement, vol 8, no. 6, O-35, pp. 13.
  • Brown, I., Heys, SD. & Schofield, AC. (2007). 'Molecular profile of acquired docetaxel resistance in breast cancer cells'. European Journal of Cancer. Supplement, vol 5, no. 4, pp. 93-93.
    [Online] DOI: 10.1016/S1359-6349(07)70451-2
  • Brown, I., Heys, SD. & Schofield, AC. (2007). 'Gene expression profile associated with docetaxel resistance in breast cancer cells'. European Journal of Cancer. Supplement, vol 5, no. 3, pp. 15-15.
    [Online] DOI: 10.1016/S1359-6349(07)71737-8
  • Muthkumarasamy, G., Brown, I., Heys, SD. & Schofield, AC. (2007). 'Arginine inhibits cell proliferation without altering cell cycled kinetics in gastric and colorectal cancer cell lines'. European Journal of Surgical Oncology, vol 33, no. 9, P29, pp. 1108-1108.
    [Online] DOI: 10.1016/j.ejso.2007.07.015

Chapters in Books, Reports and Conference Proceedings

Chapters

  • Haggarty, P. & Heys, SD. (2012). 'Cancer'. in Nutrition & Early Development. British Nutrition Foundation, London.
  • McKenzie, H., Pennington, TH., Heys, SD. & Eremin, O. (2001). 'Sepsis'. in In: The Scientific and Clinical Basis of Surgical Practice (ed. Oremin,O.), Oxford University Press. In: The Scientific and Clinical Basis of Surgical Practice (ed. Oremin,O.), Oxford University Press.

Contributions to Conferences

Posters

  • Shaikh, I., Brown, I., Wahle, KWJ., Schofield, AC., Heys, SD. & Chaturvedi, S. (2007). 'Docosahexaenoic acid (DHA) enhances the effect of docetaxel in prostate cancer cells: Modulation of apoptotic pathways'. pp. 81-81.
    [Online] DOI: 10.1016/S1359-6349(07)70407-X

Abstracts

  • Dawson, A., Bruce, S., Heys, SD. & Stewart, IJ. (2009). 'Introducing anatomy learning packages into clinical attachments: the students'view'. pp. 797.
  • Stewart, IJ. & Heys, SD. (2009). 'Introducing anatomy learning packages into clinical attachments: a way forward'. pp. 214.
  • Dawson, A., Bruce, S., Heys, SD. & Stewart, IJ. (2009). 'The delivery of anatomy in the later years of the undergraduate medical curriculum - Do students feel this is valuable?: Do students feel this is valuable?'. Summer Meeting of The British Association of Clinical Anatomists 2009, Dundee, United Kingdom, 1/07/09,.
  • Bruce, S., Dawson, A., Heys, SD. & Stewart, IJ. (2009). 'Introducing anatomy learning packages into clinical attachments: the course co-ordinators views'.
  • Muthukumarasamy, G., Brown, I., Schofield, AC. & Heys, SD. (2007). 'Anti-tumour effect of L-arginine on gastric and colorectal cancers'. pp. 248-248.
    [Online] DOI: 10.1016/S1359-6349(07)70971-0

Books and Reports

Commissioned Reports

  • Robertson, C., Boachie, C., Burr, JM., Fraser, CM., MacLennan, GS., Mowatt, G., Ternent, L., Thomas, RE., Vale, LD., Gilbert, FJ., Dixon, M., Heys, SD., Wilson, R., Pinder, S., Bain, V., Donnelly, P., Jack, W., Kerr, G., Lawrence, G., Maxwell, A., McGregor, J. & Murchie, P. (2011). 'The clinical effectiveness and cost-effectiveness of different surveillance mammography regimes after the treatment of primary breast cancer'. NIHR Health Technology Assessment programme, Southampton, United Kingdom.
    [Online] AURA: Robertson_2011.pdf

^ top

update | about Staff Pages

‹ back